A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis

BACKGROUND: Some composite measures for determining the treatment effects of disease-modifying antirheumatic drugs on remission and low disease activity (LDA) in rheumatoid arthritis (RA) may produce misleading results if they include an acute phase reactant (APR). To inform the choice of appropriat...

Descripción completa

Detalles Bibliográficos
Autores principales: Janke, Kirsten, Kiefer, Corinna, McGauran, Natalie, Richter, Bernd, Krause, Dietmar, Wieseler, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732992/
https://www.ncbi.nlm.nih.gov/pubmed/36482451
http://dx.doi.org/10.1186/s41927-022-00314-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732992/
https://www.ncbi.nlm.nih.gov/pubmed/36482451
http://dx.doi.org/10.1186/s41927-022-00314-7

Ejemplares similares